Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma

European Journal of Dermatology

Volumn 21, Issue 3, 2011, Pages 410-411

  Tiodorovic Zivkovic, Danica ^a   Argenziano, Giuseppe ^b   Catricalà, Caterina ^c   Ferrara, Gerardo ^d   Giorgio, Caterina M ^e   Moscarella, Elvira ^c   Zalaudek, Iris ^f  

^a CLINICAL CENTER NIS   (Serbia)

^b Dermatology Unit   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^d G RUMMO HOSPITAL   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; AGED; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; DRUG TOLERABILITY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; LETTER; MALE; MELANOMA; PAPULE; PRURITUS; SCALP MELANOMA; SCALP TUMOR; SKIN METASTASIS; SKIN ULCER;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AMINOQUINOLINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; NEOPLASM STAGING; OINTMENTS; SCALP; SKIN NEOPLASMS;

EID: 79960779842     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1282     Document Type: Letter

References (6)

1. Meier F, Will S, Ellwanger U, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002; 147: 62-70.
2. Wolf IH, Richtig E, Kopera D, Kerl H. Locoregional cutaneous metastases of malignant melanoma and their management. Dermatol Surg 2004; 30: 244-7.
3. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-48.
4. Utikal J, Zimpfer A, Thoelke A, et al. Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod. Br J Dermatol 2006; 155: 488-91.
5. Schön MP, Schön M. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis 2004; 9: 291-8.
6. Bong AB, Bonnekoh B, Franke I, Schön MP, Ulrich J, Gollnick H. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology 2002; 205: 135-8.